SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Caplin Point Laboratories informs about outcome of board meeting

14 May 2026 Evaluate
Further to intimation dated May 07, 2026, Caplin Point Laboratories has informed that the Board of Directors, at its meeting held today, has declared an Interim Dividend of Rs 4.00 (200%) per equity share of face value of Rs 2 each for the financial year ended March 31, 2026; fixed May 30, 2026 as Record Date for determining the eligibility of the Shareholders for the purpose of Interim Dividend; approved the Audited standalone and consolidated financial results (including segment reporting for the consolidated results) of the Company for the year ended March 31, 2026, along with Auditors Report (Annexure-1). They also enclosed a Press Release issued by the Company (Annexure-2) and an investor presentation in this regard (Annexure-3); approved amendments to Code of Practices and Procedure for Fair Disclosure of Unpublished Price Sensitive Information. The aforesaid code has been made available on the website of the Company at https://www.caplinpoint.net/index.php/corporate-governance/ They are also enclosing the information w.r.t. Large Corporate as Annexure -4. They confirmed and declared that the Statutory Auditors of the Company i.e., Brahmayya & Co, Chartered Accountants, have issued the audit report on Standalone and Consolidated Financial Statements of the Company for the year ended March 31, 2026, with unmodified opinion. The meeting commenced at 11.10 AM and concluded at 1.10 PM.

The above information is a part of company’s filings submitted to BSE.

Caplin Point Lab Share Price

2411.30 80.50 (3.45%)
12-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1807.25
Dr. Reddys Lab 1273.90
Cipla 1388.80
Zydus Lifesciences 1104.35
Lupin 2292.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: